Latest Biotech News

Curtana Pharmaceuticals’ CT-179 is a novel, orally bioavailable small-molecule targeting OLIG2, a transcription factor driving brain tumor stem cells in glioblastoma and SHH-medulloblastoma. The...

The 2025 Nobel Prize in Physiology or Medicine honors Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for elucidating regulatory T cells (Tregs), a subset of CD4+ T lymphocytes critical for...

AstraZeneca has partnered with San Francisco-based Algen Biotechnologies in a $555 million collaboration leveraging Algen’s AlgenBrain platform, which combines single-cell CRISPR editing and...

Neurological disease-focused biotech MapLight Therapeutics progressed plans for a $227 million Nasdaq initial public offering by employing a Securities Act provision allowing registration...

The 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their groundbreaking discoveries on regulatory T cells (Tregs). These...

Peter Marks, former head of the FDA's Center for Biologics Evaluation and Research (CBER), has joined Eli Lilly as senior vice president of molecule discovery and head of infectious disease. Marks...

Skye Bioscience announced that nimacimab, its peripheral cannabinoid receptor 1 (CB1) inhibitor antibody, failed to produce significant weight loss as monotherapy in a 26-week phase 2a trial....

Italian pharmaceutical company Chiesi Group has secured exclusive global rights to Archer Biotechnologies’ ABO-101 gene editing therapy for primary hyperoxaluria type 1 (PH1), an ultra-rare kidney...

Mytos, a UK-based cell therapy manufacturing company, has inaugurated its first automated contract development and manufacturing organization (CDMO) facility located within the Cell and Gene...

Insilico Medicine researchers introduced LEGION, a hybrid artificial intelligence workflow combining mechanistic modeling with deep learning, designed to significantly expand chemical space...

Twist Bioscience and Element Biosciences extended their collaboration to develop targeted sequencing solutions optimized for Element's AVITI platform. The partnership includes releasing Twist’s...

Dublin-based biotechnology startup Aerska has announced a $21 million seed financing led by Age1, Backed VC, and Speedinvest to develop RNA interference (RNAi) therapeutics targeting neurological...

Moffitt Cancer Center has secured a $22.4 million grant from the U.S. Department of War dedicated to research and clinical trials on leptomeningeal disease, a serious complication from cancer...

The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their discovery of regulatory T cells (Tregs), a critical mechanism of...

MapLight Therapeutics, developing CNS-targeted drugs including a schizophrenia medication poised to compete with Bristol Myers Squibb's Cobenfy, is pushing forward with IPO plans amid a U.S....

Insilico Medicine unveiled LEGION, an AI-driven drug discovery workflow covering vast chemical space around the NLRP3 inflammation target. This platform seeks to optimize new compound...

Dublin-based Aerska, focused on RNA interference therapeutics for neurological diseases, raised $21 million in a seed financing round. The company’s antibody-oligonucleotide conjugate platform...

Trogenix Ltd., emerging from stealth mode, secured $95 million in Series A funding to propel its pipeline into clinical trials, focusing on a novel “Trojan horse” gene therapy approach targeting...

Bioinformatics company Golden Helix received a $2.2 million NIH Phase II SBIR grant to advance its VSPGx pharmacogenomics interpretation software. The platform analyzes next-generation sequencing...

Fujirebio Diagnostics obtained FDA clearance for the Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio Test, the first blood-based FDA-approved in vitro diagnostic for Alzheimer’s disease. This...